Granulysin (GNLY) Gene Polymorphism and serum Interleukin 23 level in Psoriasis patients in Benha University Hospital
El Mosallamy, W., Mustafa, A., Arafa, R., Saleh, S., Mostafa, M. (2022). Granulysin (GNLY) Gene Polymorphism and serum Interleukin 23 level in Psoriasis patients in Benha University Hospital. EKB Journal Management System, 31(2), 109-114. doi: 10.21608/ejmm.2022.228835
Wafaa A. El Mosallamy; Amany I. Mustafa; Roshdan M. Arafa; Sally Aly Saleh; Mysa S. Mostafa. "Granulysin (GNLY) Gene Polymorphism and serum Interleukin 23 level in Psoriasis patients in Benha University Hospital". EKB Journal Management System, 31, 2, 2022, 109-114. doi: 10.21608/ejmm.2022.228835
El Mosallamy, W., Mustafa, A., Arafa, R., Saleh, S., Mostafa, M. (2022). 'Granulysin (GNLY) Gene Polymorphism and serum Interleukin 23 level in Psoriasis patients in Benha University Hospital', EKB Journal Management System, 31(2), pp. 109-114. doi: 10.21608/ejmm.2022.228835
El Mosallamy, W., Mustafa, A., Arafa, R., Saleh, S., Mostafa, M. Granulysin (GNLY) Gene Polymorphism and serum Interleukin 23 level in Psoriasis patients in Benha University Hospital. EKB Journal Management System, 2022; 31(2): 109-114. doi: 10.21608/ejmm.2022.228835

Granulysin (GNLY) Gene Polymorphism and serum Interleukin 23 level in Psoriasis patients in Benha University Hospital

Egyptian Journal of Medical Microbiology
Article 17, Volume 31, Issue 2, April 2022, Page 109-114  XML PDF (444.5 K)
Document Type: New and original researches in the field of Microbiology.
DOI: 10.21608/ejmm.2022.228835
View on SCiNiTO View on SCiNiTO
Authors
Wafaa A. El Mosallamy1; Amany I. Mustafa2; Roshdan M. Arafa1; Sally Aly Saleh email 3; Mysa S. Mostafa1
1Department of Medical Microbiology and Immunology, Faculty of Medicine, Benha University, Egypt
2Department of Dermatology, Venerology and Andrology, Faculty of Medicine, Benha University, Egypt
3Medical Microbiology and Immunology Department, Faculty of Medicine, Kafr Elsheikh University,Egypt
Abstract
Background: Psoriasis is a chronic, non infectious, relapsing inflammatory skin disease caused by genetic, immunological and other factors in the environment, affecting 2–5% of the world’s population . Granulysin is an anti-microbial peptide that contributes to local amplification of inflammation. The activation and  maintenance of the T helper 17 pathway is the essential role of of IL23 in the pathogenesis of  psoriasis. Objectives: Evaluation of the relation of granulysin (GNLY) gene single nucleotide polymorphism to psoriasis pathogenesis, measurement of interleukin23 (IL23) level in sera of cases of psoriasis and its relation to disease severity. Methodology: our study was done on 50 subjects divided into 2 groups:30 psoriasis patients, selected from Outpatients Clinics of Dermatology, Venerology and Andrology Department of Benha University Hospitals, and 20 apparent healthy control subjects of matched sex and age. Four ml venous blood samples were collected from psoriasis patients and control subjects to genotype GNLY rs7908 (C/G) and GNLY rs10180391(C/T) polymorphisms  by Polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP)-based analysis and detection of interleukin (IL23) level using ELISA. Results: GNLY rs7908 CC genotype was significantly lower in psoriasis patients (6.7%) than in the control group (30%). The difference between patients and controls for GNLY rs10180391 allele frequen­cies was not statistically significant. IL23 level increased significantly with increased severity of psoriasis. Conclusion: GNLY rs 7908 gene polymorphismhad a significant relation with severity of psoriasis. IL23 level was directly proportional to the severity of psoriasis.
Keywords
Granulysin; gene polymorphism; IL23 level; psoriasis
Statistics
Article View: 156
PDF Download: 134